Name | (+)-JNJ-A07 |
---|
Description | (+)-JNJ-A07 is a highly potent, orally active pan-serotype dengue virus inhibitor targeting the NS3-NS4B interaction. (+)-JNJ-A07 exerts nanomolar to picomolar activity against a panel of 21 clinical isolates. (+)-JNJ-A07 has a favourable pharmacokinetic profile that results in outstanding efficacy against dengue virus infection in mouse infection models[1]. |
---|---|
Related Catalog | |
In Vitro | (+)-JNJ-A07 has a high barrier to resistance and prevents the formation of the viral replication complex by blocking the interaction between two viral proteins (NS3 and NS4B)[1]. |
References |
Molecular Formula | C28H26ClF3N2O6 |
---|---|
Molecular Weight | 578.96 |